Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2
AstraZeneca
AstraZeneca
Australasian Gastro-Intestinal Trials Group
Bristol-Myers Squibb
UNICANCER
Icahn School of Medicine at Mount Sinai
H. Lee Moffitt Cancer Center and Research Institute
University of Kansas Medical Center
University of Chicago
University of Utah
H. Lee Moffitt Cancer Center and Research Institute
Bristol-Myers Squibb